Authors
Latest:
February's Special Report: Child and Adolescent PsychiatryDiscover key insights from February’s Special Report on child and adolescent psychiatry, exploring overlooked diagnoses, new research, and the complex impact of social media on youth mental health.
Latest:
Autism Spectrum Disorders and Psychiatry: Update on Diagnostic and Treatment ConsiderationsWhat are the most effective assessment practices for ASD during the developmental stages of early childhood, middle childhood, adolescence, and adulthood?
Latest:
Reading the Ability of a Patient to Change His or Her LifeReading the Ability of a Patient to Change His or Her Life
Latest:
The Cognitive Behavioral Analysis System of PsychotherapyI have been invited to write a clinical article on psychotherapeutic interventions for chronic depression.
Latest:
Coping with Diagnostic Uncertainty in Mixed States: Comparing Treatment RisksLet’s compare treatment risks when managing mixed states.
Latest:
PTSD in DSM-5: Understanding the ChangesDespite the efforts of a dedicated Work Group, DSM-5 has not significantly changed the problems with PTSD that beset DSM-IV.
Latest:
Providing Psychotherapy Over the InternetAlthough the prospect of online mental health care raises obvious questions, it also offers an opportunity to make cost effective services available to many who may not otherwise have access. By understanding issues such as confidentiality, emergencies and lack of face-to-face contact, psychiatrists can determine if this area of treatment is right for them.
Latest:
Multiple Sclerosis: MRI in Diagnosis, Management, and MonitoringMRI has provided important insights into the pathophysiology of multiple sclerosis (MS).1 However, conventional MRI scans furnish only gross estimates of the nature and extent of tissue damage associated with MS,2 and the data correlate poorly with measures of concurrent disability in patients.
Latest:
Psychosomatic Medicine: An Idea Whose Time Has ComeMedical-psychiatric comorbidity predicts poorer outcomes and increased health care utilization and cost. The collection of articles in this Special Edition is clinically informative and an illustrative set of examples of the unique practice of psychosomatic medicine in different medical-surgical settings.
Latest:
Use of a Nasal Naloxone-Containing Kit in the Transition From Regional Psychiatric Hospital to Community Care: A 1-Year Follow-up StudyDetails here about a protocol for opioid abusers and the mentally ill that helped avoid deaths from drug overdose after psychiatric hospitalization.
Latest:
Anti-NMDA Receptor Encephalitis: Diagnostic Issues for PsychiatristsThis articles focuses on the psychiatric and neurological implications of anti-NMDA receptor encephalitis.
Latest:
It’s Still Possible-Even in a Managed Care WorldIt is still possible for a psychiatrist to have a successful and very gratifying practice that provides psychotherapy (along with medication to those who need both)-even “in a managed care environment.”
Latest:
The Conundrum of Psychiatric ComorbiditySince the revision of DSM-III, high rates of co-occurring psychiatric disorders have been observed, particularly in cases of moderate and severe psychiatric illness. The reason lies in the design of the diagnostic system itself: DSM-IV is a descriptive, categorical system that splits psychiatric behaviors and symptoms into numerous distinct disorders, and uses few exclusionary hierarchies to eliminate multiple diagnoses.
Latest:
Reexperiencing/Hyperaroused and Dissociative States in Posttraumatic Stress DisorderDissociation-a common feature of posttraumatic stress disorder (PTSD)-involves disruptions in the usually integrated functions of consciousness, memory, identity, and perception of the self and the environment.
Latest:
Antidepressants: Brand Name or Generic?For many antidepressants, the issue of brand-name versus generic has no practical significance. Elavil was first marketed almost a half century ago, and its patent has long expired. It lives on, however, but as generic amitriptyline. Today, only a few antidepressants are still fully protected by patents, namely, Cymbalta (2010), Lexapro (2012), and Pristiq (2022) for major depressive disorder (MDD); and Seroquel (2011) and Symbyax (2017) for bipolar depression.
Latest:
Does Ketamine Hold Promise in Mitigating Suicide Risk?The authors review mechanisms of suicide and the effectiveness of current treatments, and zero in on ketamine--a potential novel, rapidly acting treatment for suicidality.
Latest:
The Assessment and Management of Depression in Children With AsthmaAsthma is one of the most impairing diseases of childhood, affecting more than 6% of children. Each year, it is responsible for 14 million lost school days and $3 billion in treatment costs.
Latest:
Rock, Paper, Scissors-PicaPica, a condition in which a person is compelled to eat non-food items such as dirt, paper, plaster, cigarette ashes, and other substances, is increasing in prevalence in adults. More in this patient education summary.
Latest:
Exploring Gender Difference in DepressionMost studies have found clear gender differences in the prevalence of depressive disorders. Typically, studies report that women have a prevalence rate for depression up to twice that of men (Bebbington, 1996; Nolen-Hoeksema, 1987).
Latest:
Managing Treatment-Resistant OCDObsessive-compulsive disorder is a prevalent, disabling and chronic illness. Serotonin reuptake inhibitors are the first-line of treatment; however a large proportion of patients will have either a partial or nonresponse. This review outlines the strategies for treatment-resistant OCD, including augmentation agents, alternative monotherapies, intravenous strategies and newer nonpharmacologic somatic treatments under development.
Latest:
Insomnia and Its Risks: Causes, Consequences and TreatmentCMEducator: Insomnia and Its Risks: Causes, Consequences and Treatment - application for credit only; article not available online
Latest:
Final Ruling Can Benefit Psychiatrists and Their PatientsThe mental health community was given some much needed relief when the Obama Administration implemented the final rule be put in place from the 2008 Mental Health Parity and Addiction Equity Act. The new mandate will ensure that most health plans cover mental health and addiction services in the same way they treat other medical issues.
Latest:
Coming Up for AirAs I lie in my hospital bed, attempting to breathe through my trach tube at a normal rate, waiting for my morning medication, and hoping to hear good, or at least manageable, results from my doctors when they come to me on rounds, my mind wanders. Despite the precariousness of my situation, I can’t help but smile as I think of my now monthly psychotherapy sessions.
Latest:
Psychopharmacology of Aggression and Violence in Mental IllnessSeveral studies have been undertaken to test the efficacy of drugs in the management of aggression and hostility in patients with schizophrenia and other mood disorders.
Latest:
Is ECT an Ethical Treatment?Although there are many social impediments to the use of ECT, it appears to meet the four ethical principles of health care.
Latest:
Sleep Disorders in the ElderlyA variety of conditions may account for the sleep difficulties experienced by many older adults, including specific sleep disorders, circadian rhythm disturbances, and medical and psychiatric comorbidities.
Latest:
How Does Psychiatry Interface With Creativity?Discover how psychiatry and creativity intertwine, exploring the link between mental health and artistic expression.
Latest:
Optimizing Care in a Team Setting: A Program for People With SchizophreniaA look at a multidisciplinary team -- and its focus on meaningful recovery -- for patients with schizophrenia.
Latest:
Enlisting Family Members to Address Treatment Refusal in Substance AbusersAnyone who is close to someone who abuses alcohol or drugs knows all too well that substance abusers do not typically seek treatment until they have experienced years of substance-related problems. During the first year after onset of a diagnosable substance use disorder, only 1 of 5 alcohol-dependent persons and 1 of 4 drug-dependent persons receive treatment.
Latest:
2021 Sigourney Award Winner: Supporting the MissionThis Sigourney Award winner is glad the recognition can continue supporting the mission of their work.
